Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Study Evaluating 3 Chemotherapy Regimens as Second-line Treatment in Patients With Hormone-refractory Metastatic Prostate Cancer

NCT00627354 is registered in ClinicalTrials.gov with Groupe D'Etude des Tumeurs Uro-Genitales as lead sponsor.

NCT NCT00627354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00627354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Study Evaluating 3 Chemotherapy Regimens as Second-line Treatment in Patients With Hormone-refractory Metastatic Prostate Cancer
Lead sponsor
Groupe D'Etude des Tumeurs Uro-Genitales
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2006
Completion date
Not reported
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer